Who is sponsoring NCT04564807?

NCT04564807 is sponsored by Jessica Weafer.

What drugs are being tested in NCT04564807?

Interventions in NCT04564807: Web-Based Insomnia Education Program, SHUTi Intervention.

What condition does NCT04564807 study?

NCT04564807 studies Alcohol Use Disorder, Insomnia.

Is NCT04564807 still recruiting?

NCT04564807 is currently completed. Last updated 25 October 2022.

Last reviewed 2022-10-25 · How we verify

NCT04564807

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Testing an Online Insomnia Intervention

Completed NA Last updated 25 October 2022

What this trial tests

NA trial testing Web-Based Insomnia Education Program in Alcohol Use Disorder in 71 participants. Completed in 31 May 2022.

Timeline

25 September 2020

Primary endpoint
31 May 2022

31 May 2022

Quick facts

Lead sponsor	Jessica Weafer
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	71
Start date	25 September 2020
Primary completion	31 May 2022
Estimated completion	31 May 2022
Sites	1 location across United States

Drugs / interventions tested

Web-Based Insomnia Education Program
SHUTi Intervention

Conditions studied

Alcohol Use Disorder — all drugs for Alcohol Use Disorder →
Insomnia — all drugs for Insomnia →

Sponsor

Jessica Weafer

Who can join

Adults 21 to 50, any sex, with Alcohol Use Disorder or Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this trial is to determine the effectiveness of an electronic cognitive behavioral therapy for insomnia (e-CBT-I) module in improving sleep and reducing alcohol use among heavy drinkers with insomnia. Specifically, it will test the effectiveness of Sleep Healthy Using the Internet (SHUTi), a well-validated version of e-CBT-I comprised of 6 weekly educational modules and daily sleep diaries. The rationale for this mixed methods proposal is that effective, nonpharmacologic treatments are necessary to stem the highly comorbid public health problems of alcohol use disorder (AUD) and insomnia. If successful, SHUTi will represent a novel and easily accessible intervention for reducing alcohol intake among high-risk heavy drinkers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of a digital cognitive behavioral therapy for insomnia on sleep and alcohol consumption in heavy drinkers: A randomized pilot study.
Verlinden JJ, Moloney ME, Vsevolozhskaya OA, Ritterband LM, et al · · 2023 · cited 12× · PMID 38099849 · DOI 10.1111/acer.15209

Verify or expand the search:

Other trials of Web-Based Insomnia Education Program

Trials testing the same drug.

NCT05630118 — Online Insomnia Intervention to Reduce Alcohol Use · NA · completed

Other recruiting trials for Alcohol Use Disorder

Currently open trials in the same condition.

NCT06860607 — Environment and Alcohol: A Pilot Study · Phase 1 · recruiting
NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
NCT07046819 — Tirzepatide in MetALD · Phase 2 · recruiting
NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis · NA · recruiting

Other Jessica Weafer trials

Trials by the same sponsor.

NCT05929677 — Impulsivity Domains and Subjective Response · EARLY_PHASE1 · recruiting
NCT05630118 — Online Insomnia Intervention to Reduce Alcohol Use · NA · completed
NCT04929288 — Neural and Hormonal Influences on Sex Differences in Risk for AUD · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04564807 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jessica Weafer
Last refreshed: 25 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04564807.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing